The Medical Innovation Podcast

In this episode, we speak with Dani Marques, co-founder and CEO of SkinCheck, about using AI to close the dermatology access gap for the nearly 10,000 Americans diagnosed with skin cancer daily. Dani explains how SkinCheck combines a consumer skin monitoring app with a 24 to 48-hour digital consultation service, and how a patented domain adaptation technique addresses racial bias in dermatology AI...

In this episode, we speak with Jaimal Soni, co-founder and CEO of Insight Health, about automating the clinical operations stack for independent specialty practices using agentic AI. Jaimal explains how Insight Health's Magic Flow orchestration layer strings together multiple AI agents to manage the full patient journey, from intake through scheduling and chronic disease follow-up, while their...

In this episode, we speak with Dr. David Lortscher, founder of Curology and a board-certified dermatologist, about building the first telehealth platform to combine custom compounded medications with direct-to-consumer acne care, growing it to $200 million in revenue and 5 million patients treated. He shares how he licensed himself in all 50 states, drove consultation costs to $5, and built a 50,0...

In this episode, we speak with Jason Woosley, Chief Product Officer at Omnicell, about bringing Silicon Valley product thinking to pharmacy automation. Jason shares how his background scaling Magento and the Adobe Commerce Cloud is shaping a new approach to hardware, software, and team structure at Omnicell, including a shift toward cloud-based infrastructure, agile AI-assisted teams, and a modula...

In this episode, we speak with Dr. David Carmouche, Chief Medical Officer at Lumeris, about using agentic AI to solve the primary care shortage. He explains how Lumeris built Tom, a 24/7 AI care team member named in honor of co-founder Tom Doerr, that handles proactive outreach, symptom triage, visit preparation, and clinical decision support grounded in real patient data. We discuss why safety an...

In this episode, we speak with Dr. Jhonatan Bringas Dimitriades, co-founder and CEO of Lapsi Health, about Keikku, an FDA-cleared device that merges digital auscultation, ambient AI scribing, and voice biomarker analysis into a single clinical platform. Jhonatan explains how Lapsi Health is rethinking the stethoscope not as a niche device, but as the hardware foundation for a comprehensive healthc...

In this episode, we speak with Dr. Tom Kelly, CEO and founder of Heidi, about the platform's evolution from a free AI scribe into a multi-product clinical AI suite now supporting nearly 2.5 million visits per week across 116 countries. Tom explains how Heidi's two newest products, Evidence and Comms, give clinicians agentic tools to query medical literature, conduct surgical audits, and en...

In this episode, we speak with Tina Liedtky, Global President of Transplant Diagnostics at Thermo Fisher Scientific, about how cutting-edge diagnostics and emerging AI are reshaping organ transplantation. Tina explains how HLA compatibility testing underpins successful transplant outcomes and how innovations like the non-invasive CXCL10 urinary biomarker are expanding access to post-transplant mon...

In this episode, we speak with Dr. Holly Urban, VP of Business Development at Wolters Kluwer and a pediatrician-turned-health-IT-leader, about how UpToDate is bringing AI into clinical decision support without compromising safety or trust. She explains how UpToDate Expert AI grounds its responses exclusively in curated expert content, acts as a virtual attending physician by prompting clinicians w...

In this episode, we speak with Joseph Sokol and Roman Sandler, co-founders of iCardio.ai, about their mission to fully automate echocardiograms using AI. They explain how their two FDA-cleared products - EchoMeasure, which automates over 60 echo measurements, and CardioVision, which screens for aortic stenosis via standard ultrasound - are reshaping cardiac diagnostics by integrating directly into...

In this episode, we speak with Chris Economos, Senior VP of Business Development at Eko, about how the company is transforming the humble stethoscope into an AI-powered diagnostic platform capable of detecting heart failure, AFib, and structural heart disease. Chris explains how Eko's Core 500 device captures both acoustic and ECG signals to deliver specialist-level insights in 5 to 15 seconds...

In this episode, we speak with Dr. Amit Phull, Chief Clinical Experience Officer at Doximity and practicing ER physician, about how the platform serving over 80% of US doctors is approaching healthcare AI. Amit walks us through Doximity's evolution across three eras: from network building to workflow tools to AI-powered solutions like DoximityGPT and Scribe. We discuss their "human in the...

In this episode, we speak with Alex Frenkel, clinical psychologist and founder of Kai.ai, about building an AI companion named Kai that delivers mental health support at scale. Alex explains Kai.ai's innovative "two-contact" architecture pairing always-available AI with human clinical oversight, and how the platform avoids the "sycophantic" tendencies of general chatbots by...

In this episode, we speak with Jim Foote, CEO of First Ascent Biomedical, about functional precision medicine and why testing drugs on a patient’s own tumor cells could transform cancer treatment. Jim explains how their CLIA-certified lab cultures live cancer cells and uses robotics and AI to test hundreds of drug combinations in just 10 days, achieving an 83% correlation with patient outcomes in...

In this episode, we speak with Henry O'Connell, co-founder and CEO of Canary Speech, about using voice as a biomarker to detect conditions ranging from anxiety and depression to cognitive impairment and autism. He explains how their technology analyzes 12.5 million data elements in 40 seconds of speech, working ambiently during natural conversation to provide clinicians with objective diagnost...

In this episode, we speak with Pete Durlach, Chief Strategy Officer for Microsoft Healthcare and Life Sciences, about transforming the Nuance acquisition into Dragon Copilot, an AI clinical assistant that combines dictation, ambient intelligence, and generative AI into an extensible platform. Pete explains how Microsoft is creating an "app store" model for healthcare, enabling partners t...

In this episode, we speak with Susan Tousi, CEO of DELFI Diagnostics and former Chief Commercial Officer at Illumina, about using fragmentomics and AI to detect cancer through a simple blood draw. Susan explains how Delfi's whole-genome approach analyzes the structural chaos of tumor-derived DNA rather than hunting for specific mutations, dramatically reducing cost while maintaining sensitivit...

In this episode, we speak with Dr. Thomas Kelly, founder and CEO of Heidi, about building an AI care partner that eliminates administrative burden and restores the physician-patient relationship. Thomas explains how Heidi evolved from an ambient scribe into a comprehensive platform handling documentation, patient communication, and clinical support with a critical focus on personalization that ens...

In this episode, we speak with Anand Iyer, Chief AI Officer at Welldoc and former wireless technology strategist, about using AI to transform chronic disease management between doctor visits. Anand explains how BlueStar, Welldoc's FDA-regulated cardio-metabolic platform, provides precision coaching to patients while delivering clinical decision support that helps physicians overcome clinical i...

In this episode, we speak with Demetri Giannikopoulos, ChiefInnovation Officer at Rad AI, about transforming radiology workflows with AI-powered documentation. He explains who Rad AI’s cloud-native platform automates impression generation in each radiologist’s unique voice while saving an hour per shift and reducing addendums by 10-15%. With 30% of US radiologists already using their platform and...

In this episode, we speak with Mathai Mammen, the CEO of Parabilis Medicines, and a former R&D leader at J&J and Merck, about drugging the previously undruggable 80% of disease-causing proteins inside cells. He explains how their Helicon platform uses AI and unnatural amino acids to create peptides that access intracellular targets unreachable by other drugs. We discuss their lead program’...

We recently got back from HLTH 2025 in Las Vegas, and it was an incredible experience. The event truly felt like Coachella for medicine. We had the chance to connect with innovators building at the intersection of healthcare and technology, strengthen relationships with physicians driving health tech forward, record content with more than a dozen companies, and even meet Mark Cuban. We also took s...

In this episode, we speak with Dr. Justin Chen, a clinical specialist at Google, about how the company is advancing healthcare through AI. Justin shares insights into projects like Med-Gemini and Med-Gemma, and why AI in medicine is in a critical “prove it” phase where models must deliver measurable clinical value. We discuss how Google bridges technical and clinical expertise to bring these tools...

In this episode, we speak with Daniel Hawkins, CEO of Vista AI and veteran medical device innovator behind the Da Vinci robot and Shockwave Medical, about using AI to transform MRI imaging across all anatomies. Daniel explains how Vista AI's technology directly controls MRI machines to reduce scan times and skill requirements, acting as a "co-pilot" for technologists while addressing critical staf...

In this episode, we speak with Dr. Bill Weeks, Director of AI for Health at Microsoft and Medical Director of Bing, about how one of the world’s largest tech companies is supporting global health through AI. Bill shares how Microsoft partners with nonprofits and researchers to tackle challenges like health equity and medical access, and offers insight into the role of search and large language mod...